Literature DB >> 2980049

Technical considerations in reoperation for porcine bioprosthetic valve failure.

U Bortolotti1, A Mazzucco, A Milano, V Gallucci.   

Abstract

Reoperation in porcine valve recipients is becoming increasingly frequent, owing to the limited durability of the valves. In reviewing our experience with first reoperation for porcine valve failure in 191 patients over a 17-year period, we found that following certain routine surgical steps can minimize complications and improve the surgical outcome. Extended dissection of the heart is useful during mitral bioprosthetic replacement to enhance visualization of the failing device while retracting the left atrium without undue tension on fragile structures such as the left innominate vein-superior vena cava junction. This maneuver can be avoided, however, when replacement of an aortic bioprosthesis is required. Excision of a porcine valve is performed by peeling off the fibrous tissue overgrown on the sewing ring, which exposes the underlying sutures, cutting each knot, and finding a plane between the stent and the native valve annulus by careful blunt dissection. Care is taken not to cut the Dacron cloth of the sewing ring to avoid the potential for embolization of the silicone sponge contained within it. The use of this technique helps to minimize postoperative complications such as paravalvular leak or atrioventricular block and to preserve the native annulus, which facilitates insertion of a new prosthesis. Our experience indicates that first reoperation in porcine valve recipients can be performed with low risk, particularly in elective cases, and with a low incidence of complications related to repeat median sternotomy.

Entities:  

Mesh:

Year:  1988        PMID: 2980049     DOI: 10.1111/j.1540-8191.1988.tb00438.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  1 in total

1.  The risks of reoperation for prosthetic valve dysfunction.

Authors:  Y Kawachi; K Matuzaki; R Tominaga; H Yasui; K Tokunaga
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.